Jeffrey A. Porter

1 ta ish

Novartis (United States)

1. Variation in Microbiome LPS Immunogenicity Contributes to Autoimmunity in Humans

   Tommi Vatanen, Aleksandar D. Kostic, Eva d’Hennezel +22

   Maqola20162 iqtibos

   ABIABI:AkademIndex/2026.other.344573